Differential expression of distinct surface markers in early endothelial progenitor cells and monocyte-derived

Shu-Meng Cheng1, Shing-Jyh Chang2, Tsung-Neng Tsai1

  • 1Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

Gene Expression
|January 9, 2014
PubMed

Insights

Distinguishing early endothelial progenitor cells (EPCs) from monocytes is crucial for cell therapies. Early EPCs share gene expression profiles most similar to monocyte-derived macrophages (MDMs), suggesting new isolation markers.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Endothelial progenitor cells (EPCs) are vital for blood vessel formation.
  • Early EPCs exhibit properties similar to monocytes, complicating their isolation.
  • Pure EPC populations are needed for clinical applications like cardiovascular disease treatment.

Purpose of the Study:

  • To compare gene expression profiles of early EPCs with various blood and endothelial cells.
  • To identify novel biomarkers for distinguishing early EPCs from monocytes and macrophages.
  • To understand the molecular basis for early EPC similarity to monocyte-derived macrophages.

Main Methods:

  • Gene expression profiling of early EPCs, peripheral blood mononuclear cells, monocytes, monocyte-derived macrophages (MDMs), mature endothelial cells, late EPCs, and CD133+ stem cells.
  • Analysis of mRNA profiles to determine cell type similarities.
  • Gene Ontology database search to explore functional significance.
  • Identification of novel plasma membrane genes as potential biomarkers.

Main Results:

  • Early EPCs showed the highest mRNA profile similarity to MDMs compared to all other cell types.
  • Novel potential biomarkers were identified: CLEC5A (high in MDMs), SIGLEC8, and KCNE1 (abundant in early EPCs).
  • Detailed expression profiles and functional modules were elucidated.

Conclusions:

  • Early EPCs molecularly resemble MDMs more than other cell types.
  • Identified genes like SIGLEC8 and KCNE1 may serve as novel biomarkers for purifying early EPCs.
  • These findings can advance cell isolation techniques for therapeutic applications in angiogenesis-related diseases.